Type II diabetes mellitus, a major constituent of metabolic diseases, is clinically hallmarked by hyperglycemia, impaired peripheral response to insulin (i.e., insulin resistance) and pancreatic β-cell decompensation. Here, INS is linked to type 2 diabetes mellitus.